CORDIS - EU research results
CORDIS

Psychiatric disorders and Comorbidities caused by pollution in the Mediterranean area

Project description

The link between anthropogenic pollutants and psychiatric disorders

Pollution has been linked with psychiatric disorders and comorbidities. The EU-funded PsyCoMed project will consider the role of anthropogenic pollutants as a risk factor for neuropsychiatric disorders and associated pathologies in the Mediterranean area. It will investigate the role of neuroinflammatory responses in disease progression. This MSCA Staff Exchange programme will merge molecular and clinical science, mechanistic and behavioural approaches and intersectoral strategies to compare the effects of pollutants on psychiatric symptoms with alterations of inflammatory pathways in animal models and psychiatric patients. By investigating neural mechanisms underlying pathological changes in vitro and in vivo preclinical models, the project aims to standardise protocols and experimental design, and propose therapeutic strategies.

Objective

The PSYchiatric disorders and COmorbidities caused by pollution in the MEDiterranean area (PsyCoMed) project proposes a MSCA-Staff Exchange program that aims to characterise the role of anthropogenic pollutants in the Mediterranean area as a risk factor of neuropsychiatric disorders and associated pathologies, and the role of neuroinflammatory responses in the disease progression. The consortium comprises 11 beneficiaries (8 academic, 3 SMEs) and 3 TC partners putting together complementary expertises in environmental and life sciences (academics) and analytical biology or natural therapeutic phytocompounds (SMEs). Through a multi-scale (from molecular to clinical science), multi-modal (from mechanistic to behavioural approaches), and inter-sectoral strategy, PsyCoMed will correlate the effects of pollutants on psychiatric symptoms with alterations of inflammatory pathways in animal models and psychiatric patients. We will investigate neural mechanisms underlying pathological changes in vitro and in in vivo preclinical models. Natural substances with therapeutic potential will be tested for their ability to restore healthy mechanisms and alleviate pathological symptoms in animal models. PsyCoMed offers a unique framework to build a network synergy by bringing together themes and scientific practises in the Mediterranean area. The partners will share knowledge/know-how through secondments and workshops in support of PsyCoMed scientific objectives. This will improve the skills of staff members and their opening to the academic and private sectors. By proposing common protocols and experimental design, the participants will foster standardization of experimental procedures and diffusion of good laboratory practise. At a global level, the consortium will acquire the capacity to tackle complex neurobiological challenges, while building long-lasting collaborations. PsyCoMed will provide decision-makers with the ground for public health orientations with societal impact.

Coordinator

UNIVERSITE DE BORDEAUX
Net EU contribution
€ 262 200,00
Address
PLACE PEY BERLAND 35
33000 Bordeaux
France

See on map

Region
Nouvelle-Aquitaine Aquitaine Gironde
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Participants (9)

Partners (4)